You are here: Home » International » News » Others
Business Standard

China likely to use medical data to blackmail Americans, says report

Biotech companies in China have access to technology and data through investments in US companies, partnerships with American universities and recruitment of US-trained researchers

Bloomberg  |  Hong Kong 

China, China flag
Photo: Shutterstock

Chinese investment in the presents a risk to national security, potentially giving China’s government access to patient data that could be used to blackmail Americans, according to a report for a Congressional advisory commission.

have access to technology and data through investments in US companies, partnerships with American universities and recruitment of US-trained researchers, the report for the US-Economic and Security Review Commission said.

“Chinese biotechnology companies are acquiring technologies crucial to advancement in the field as well as amassing large collections of clinical and genetic data on US residents,” the report published February 14 said.

New US regulations have put biotech on the same level in terms of importance to national security as aerospace and microchips.

ALSO READ: China's military: The shape of things to come

Chinese investors have been a mainstay of recent fundraising by private biotechnology firms.

At least one Chinese investor participated in 41 US biotech financing deals valued at a total of $2.6 billion last year, according to Pitchbook.

“Theoretically, access to private information on security-sensitive US persons creates a risk of blackmail and may reveal health conditions exploitable in a targeted attack,” the commission report said.

The commission, which reports to Congress on national security implications of US-trade and economic ties, released the report prepared by Gryphon Scientific, a consulting firm based in Takoma Park, Maryland, and founded by Rocco Casagrande, a former United Nations biological weapons inspector.

While noting China is “a leading originator of cyberattacks on the US” that target personal health-care-related data, the commission’s report said there was no evidence so far that the Chinese government has used such data in a “strategic and hostile way.”

First Published: Fri, February 15 2019. 23:26 IST
RECOMMENDED FOR YOU